Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ebola’s shot across the bows points to need for better global anti-infection defenses

This article was originally published in Clinica

Executive Summary

Ebola and its effects, devastating as they are, are likely to be overcome and controlled with behavioral change and rigor. HIV-AIDS, SARs and avian flu are in the same bracket: all tragedies with unimaginable human consequences, but, at the risk of sounding flippant, almost as nothing compared to the effect that a highly-pathogenic novel or mutated airborne viral or bacterial disease could have in densely populated areas.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel